Footnote j added:For patients >40 years of age with 2 biopsy proven cTis-cT2 lesions (with at least one invasive site) after MRI evaluation, intending on adjuvant whole breast radiation + boost, breast conservation therapy may be considered (Boughey JC,...
Footnote j added:For patients >40 years of age with 2 biopsy proven cTis-cT2 lesions (with at least one invasive site) after MRI evaluation, intending on adjuvant whole breast radiation + boost, breast conservation therapy may be considered (Boughey JC, et al. J Clin Oncol. 2023;41:3184-...
Footnote j added:For patients >40 years of age with 2 biopsy proven cTis-cT2 lesions (with at least one invasive site) after MRI evaluation, intending on adjuvant whole breast radiation + boost, breast conservation therapy may be considered (Boughey JC, et al. J Clin Oncol. 2023;41:3184-...
Footnote hh added:Updated results from the adjuvant APHINITY trial in HER2-positive early breast cancer, with a median follow-up of 8.4 years, have confirmed the benefit of adding pertuzumab to trastuzumab plus chemotherapy in preventing invasive disease recurrence...
NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged.DCIS-2 NCCN Guidelines Version 4.2020Invasive Breast CancerNCCN Guidelines IndexTable of ContentsDiscussionee 证据支持在绝经前激素受体阳性乳腺癌女性中,手术或...
NCCN Guidelines for Patients® Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia (Pediatric) Acute Myeloid Leukemia Adolescents and Young Adults with Cancer Bladder Cancer Bone Cancer Brain Cancer/Gliomas Breast Cancer Noninvasive Breast Cancer Invasive Breast Cancer Metastatic Breast...
The updates to management of early invasive breast cancer in 2016 are minor but have important treatment implications for patients. The NCCN Guidelines Panel for Breast Cancer has added endocrine therapy to its recommendations for the neoadjuvant treatment of patients with ER-rich tumors. For women ...
In the presence of an underlying invasive breast cancer treated with breast-conserving surgery, axillary surgery should be performed according to the Surgical Axillary Staging outlined in the NCCN Guidelines. 在有潜在浸润性乳腺癌接受保乳手术的情况下,应根据NCCN指南中提出的腋窝淋巴结手术分期实施腋窝手术。
Footnote hh added: Updated results from the adjuvant APHINITY trial in HER2-positive early breast cancer, with a median follow-up of 8.4 years, have confirmed the benefit of adding pertuzumab to trastuzumab plus chemotherapy in preventing invasive disease recurrences. BINV-9 病理淋巴结阳性(≥1个同...
RVM场EKMiSinVM,H0DM?C?MVW4Cm MM* National Comprehensive CancerNetwork*NCCN Guidelines Version 2.2021 Invasive Breast CancorNCCN l/tfWitYahto PiwgotADJUVANT ENDOCRINE THERAPYatLlArorTMrtiw inhibitor for S/(c?gcry 1) PostnvnopausaT1 —* orFunacHo* fb s y (cMQory 1)| / ICoEdtr tomoxifm...